CClinicalTrials.gg
Status unknownNCT03799081Updated Jan 10, 2019

Use of Fetoscopy in Missed Abortion

An interventional study of Fetoscopy in Abortion, Missed, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-01-10.

Sponsored by Hillel Yaffe Medical Center · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of this study is to evaluate the use of hysteroscopic embryoscopy or fetoscopy as a powerful diagnostic tool to provide better counseling for couples having experienced pregnancy loss.

02

Conditions studied

  • Abortion, Missed

Browse trials for

03

In context

Abortion, Missed

53 studies on the registry are indexed under Abortion, Missed; 10 are open to participants now.

This study's planned enrollment of 100 is below the median of 142 across 44 interventional studies indexed under Abortion, Missed.

Browse Abortion, Missed studies →

Lead sponsor

Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women diagnosed with missed abortion during the first trimester of pregnancy

Exclusion criteria

Exclusion Criteria:

  • Women diagnosed with missed abortion after the first trimester of pregnancy
  • Any contraindication for hysteroscopy
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    Fetoscopy in missed abortion

    Women who have decided to undergo fetoscopy in missed abortion

    Procedure: Fetoscopy

Interventions

  • ProcedureFetoscopy

    Fetoscopy is a procedure that enables viewing of the fetus through use of a hysteroscope

06

What researchers measure

Primary outcomes

  1. Macroscopic anatomic malformations in missed abortions

    The number and type of macroscopic anatomic malformations in missed abortions will be determined through visual observation using a fetoscope

    Time frame: Two years

Secondary outcomes

  1. Minimize intrauterine adhesions through observation

    To minimize intrauterine adhesions that might occur after curettage through the ability to visualize the womb and pregnancy site through a hysteroscope before the surgical procedure so that inadvertent intrauterine adhesions are minimized. After one year, if pregnancy is not achieved (due to intrauterine adhesions that cause infertility), a follow-up hysteroscopy will be performed and intrauterine adhesions can be visualized if they have occurred.

    Time frame: Two years

  2. Prevention of retained conception products

    Prevention of retained conception products by hysteroscopy after curettage and visualization and observation of the contents of the womb

    Time frame: Two years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03799081
Lead sponsor
Hillel Yaffe Medical Center
Responsible party
Sponsor
First posted
Jan 10, 2019
Start date
Jan 2019 (estimated)
Primary completion
Jan 2021 (estimated)
Completion
Jan 2021 (estimated)
Last update
Jan 10, 2019

Study contacts

Emiliya Ilizirov, MD
Contact
emiliyailizirova@gmal.com
972-532323246
Sergio Haimovich, MD, PhD
principal investigator · Hillel Yaffe Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion